Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,16746,322,0.61 [0.48-0.78],5.569348067613562e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",16713,325,1.26 [1.16-1.38],7.82135531009038e-08
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,16755,321,0.33 [0.19-0.56],3.651924027774473e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,16643,324,1.64 [1.39-1.93],4.3610287936007805e-09
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,16244,314,1.62 [1.43-1.83],1.4489072047451485e-14
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,14680,299,1.91 [1.54-2.36],3.0859167691252382e-09
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,16572,327,1.56 [1.25-1.94],7.098935307197782e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,16960,330,2.21 [1.83-2.66],1.2476422521264262e-16
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,16854,324,1.32 [1.15-1.50],4.487667516087213e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,14670,302,2.07 [1.52-2.83],4.519911824256503e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,16918,329,1.67 [1.36-2.04],6.541064334395829e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,17000,333,1.69 [1.41-2.03],2.18028126272179e-08
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,16743,321,2.10 [1.53-2.90],5.204102825200514e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,14234,291,1.87 [1.46-2.40],7.316110723758347e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,14680,299,0.44 [0.29-0.65],4.111520151616811e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,16763,321,1.37 [1.18-1.59],3.383934576475052e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,14622,300,1.36 [1.19-1.55],4.056353101186115e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,14380,294,0.53 [0.39-0.73],9.986954654603724e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,16500,326,1.39 [1.19-1.62],1.9630667501459844e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,16935,330,1.60 [1.34-1.91],1.620714475581906e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,16880,325,0.52 [0.39-0.70],1.776686410665517e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,16808,326,1.53 [1.30-1.80],2.2699544010575461e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,16918,329,0.36 [0.23-0.57],7.828223448764336e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,16591,325,2.11 [1.65-2.69],2.284714203536885e-09
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,16734,320,1.70 [1.36-2.12],3.561444989479525e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,16918,329,0.53 [0.39-0.73],6.546946993570528e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,14380,294,2.41 [1.61-3.62],2.1603865199462065e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,14640,302,3.89 [2.29-6.58],4.436005036961428e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,16439,321,1.56 [1.34-1.82],8.075739527057907e-09
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,16776,326,1.42 [1.23-1.64],1.639610960429346e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,16947,331,0.54 [0.42-0.69],6.671602354113748e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,16824,325,0.45 [0.31-0.64],1.5760007595468405e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,16762,327,2.12 [1.48-3.03],4.477711425060866e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,14300,291,0.51 [0.37-0.71],5.522065767538139e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,16643,324,1.39 [1.22-1.59],1.4499150347889589e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,16643,324,1.46 [1.25-1.70],9.793851419582616e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,16979,332,2.06 [1.59-2.67],5.358865496508001e-08
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,16643,324,0.51 [0.41-0.63],1.5207440986206754e-09
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,16773,322,1.55 [1.30-1.85],1.1438197207390046e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,15967,311,2.24 [1.85-2.71],1.061304894611075e-16
